Navigation Links
Van Andel Institute and Children's Memorial Research Center of Chicago Form a Partnership to Facilitate Pediatric Research
Date:2/26/2008

XenoBase software can be used to develop more effective treatments for pediatric patients

GRAND RAPIDS, Mich., Feb. 26 /PRNewswire-USNewswire/ -- Van Andel Institute (VAI) has entered into a multi-year licensing agreement with Children's Memorial Research Center (CMRC) of Chicago for use of its XenoBase software and database system.

XenoBase is a unique, advanced bio-informatic system created by scientists at Van Andel Research Institute (VARI) to support all aspects of the life sciences from basic research discovery to clinical application. The platform holds great promise for researchers and clinicians who use the system to explore the molecular and clinical basis of disease. In recent applications, physicians have used the tool to match the molecular profile of tumors of late-stage cancer patients to the most effective therapy, based on molecular evidence.

"The XenoBase technology holds great promise for the future as we evolve toward a more proactive standard of health care," said VAI Chairman & CEO David Van Andel. "We are pleased to enter into this agreement with an internationally recognized research center under the fine leadership of Dr. Hendrix who is dedicated to producing innovative solutions to prevent, diagnose and treat diseases affecting children."

CMRC is the research arm of Children's Memorial Hospital (CMH), the pediatric teaching hospital for Northwestern University's Feinberg School of Medicine. It is one of only a handful of institutions in the United States dedicated exclusively to pediatric research. Like the researchers at VARI, the research team of CMRC will use XenoBase to explore the molecular and clinical basis for disease and to support the discovery of novel approaches to alleviate pain and suffering due to disease.

"As a result of this agreement between CMRC and VARI, we anticipate novel collaborations using XenoBase to more quickly impact human disease," said Mary J.C. Hendrix, Ph.D
'/>"/>

SOURCE Children's Memorial Hospital
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
2. Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
3. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
4. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
5. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
6. China Holdings Announces Starwood Research Institute Initiates Research Coverage
7. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
8. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
9. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
10. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
11. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2009)...th care may explain results, study says , ...ple in the United States scored better than their ...test, possibly because of differences in levels of...an adults receive more aggressive treatment for he...ssessed immediate and delayed recall of 10 common ...
(Date:7/3/2009)...Reward and recognise service excellence during Nat... London (PRWeb UK) July 3, 200... are being urged to celebrate the importance of ex...l Customer Service Week - 5-11 October., , ,Employ...he corner shop and local authority see the week, w...
(Date:7/3/2009)...hat finding will lead to treatments, , ,...hers say they,ve found a major cellular flaw that .... , When caught early, lung cancer can often be...e disease is well advanced. Though doctors can som...often springs back more virulent than ever, freque...
(Date:7/3/2009)...A new urine drug test kit called DrugConfirm&trade...als that want a fast and accurate instant drug tes...s, the cup has a sleek, innovative design and inco...so very competitively priced compared to the other...on the market , San Diego...
Breaking Medicine News(10 mins):Health News:On Memory, Older Americans Outsmart the English 2Health News:Businesses Urged to Sign Up and Celebrate Customer Service 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3
...tish research, women who take large quantities of ...gh risk of developing pre-eclampsia. // Vitamins ... study by the charity Tommy's found women at high-...s of any kind of vitamins. Up to 25,000 British ...
... granted a credit of 5.1 million dollars, repayabl...t bird flu. // Further help is expected from the W...n the crossroads between Europe and Asia, especial...s health care systems. Earlier this month five pe...
...the European Commission would be targeted towards ...V/AIDS, tuberculosis (TB) and malaria // that are ...me for Action to Confront HIV/AIDS, malaria and TB...eat year. The main focus of the programme would be...
... people living with HIV/AIDS have opposed a patent...thKline for Combivir, a fixed dose combination AID...ment unaffordable. // Represented by the Lawyers... Network of People Living with HIV/AIDS and the Ma...
Other Medicine News:Health News:Control And Prevention Of Three Diseases To Be Discussed: European Commission 2Health News:HIV Patients Opposes Patenting Of AIDS Drug 2
(Date:7/1/2009)... , REYKJAVIK, Iceland, July 1 /PRNewswire-F... schizophrenia ever undertaken has revealed severa...ce of the human genome (SNPs) linked to,risk of t...um of scientists,led by a team from deCODE geneti... than 50,000 patients and control participants fro...
(Date:6/30/2009)... , MIDLOTHIAN, Va., June 30 In ...s LC Plus nebulizer and PRONEB compressors (Ultra ...moterol fumarate (Perforomist, DEY LP, Mylan Inc.)...sed that researchers chose PARI products as the ex...ring maintenance treatments for COPD. Sutherland ...
(Date:6/30/2009)... , SAN DIEGO, June 30 Calixa Th...a Phase 2 clinical trial of CXA-101 in patients wi...is a new broad-spectrum, parenteral cephalosporin ... activity against Pseudomonas aeruginosa , includ...ing CXA-101 as a potential treatment for serious b...
(Date:6/29/2009)... , ROCHESTER, Minn., June 29 /PRNewswire-USNews...gate the effectiveness of deep brain stimulation...mpulsive disorder (OCD) and Tourette,s syndrome ar...world, according to a review in the June 2009 issu...stimulation has long been seen as valuable for con...
Breaking Medicine Technology:deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration 3420 1Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration 3420 2ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair 3418 1ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair 3418 2Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 1Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 2Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 3Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 4MacuSight Expands Management Team With Appointment of Dr Joel Naor as Chief Medical Officer 12332 1MacuSight Expands Management Team With Appointment of Dr Joel Naor as Chief Medical Officer 12332 2
...8, 2007 - Biovest,International, Inc. (OTCBB: BVTI...maceuticals, Inc. (NASDAQ:ABPI), announced on June...ts fast-tracked,pivotal Phase 3 clinical trial of ... September 2000 through June 2006. This interim,bl...ade available,to the Company prior to its latest m...
...al Myeloma Workshop -, NORTH HOLLYWOOD, Calif., an...nternational Myeloma Foundation (IMF) --,supportin...upport,for myeloma patients, families, researchers...ics reported at the 11th International,Myeloma Wor...a wide,range of myeloma patients. Among the findin...
Other Medicine Technology:Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 2Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 3Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 4Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 5The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 2The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 3The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 4
...movent® T helps provide protection to the expo...l and extremely lightweight making it ideal for ac... rate of heat and moisture recovery, it ensures pa...All HMEs and filters have ISO standard tapered end...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines
Indications For Usage: , ,For use during pulmonary lung function testing
...movent® T helps provide protection to the expo...l and extremely lightweight making it ideal for ac... rate of heat and moisture recovery, it ensures pa...All HMEs and filters have ISO standard tapered end...
Medicine Products: